Patents Represented by Attorney Carolyn D. Moon
-
Patent number: 5545660Abstract: This invention relates to novel hydrazide acyl hydrazinium derivatives of certain 3,4-dihydro-2H-1-benzopyrans of the formula ##STR1## the stereoisomers and mixtures thereof, their inner salts, and the pharmaceutically acceptable salts thereof whereinR is H or C.sub.1-6 alkyl,R.sub.1 is C.sub.1-6 alkyl,R.sub.2 is H or --C(O)R,R.sub.3 and R.sub.4 are independently C.sub.1-6 alkyl;R.sub.5 is C.sub.1-6 alkyl, or ##STR2## with R.sub.8 being H or halogeno, n is zero, 1, 2, or 3 andis a halide, --S(O).sub.3 R.sub.6, or nothing when the inner salt is formedR.sub.6 is H, C.sub.1-6 alkyl, phenyl or 4-methylphenyl,to the intermediates, processes and techniques for their preparation, to their ability to manifest the property of being free radical scavengers, and to their end-use application in the treatment of disease conditions capable of being ameliorated by free radical scavengers.Type: GrantFiled: October 6, 1994Date of Patent: August 13, 1996Assignee: Merrell Pharmaceuticals Inc.Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
-
Patent number: 5536732Abstract: This invention relates to novel N-derivatives of 1-deoxy nojirimycin, to the method for their preparation and to their use in the treatment of diabetes and the use against retro-viruses, particularly in the treatment of acquired immuno-deficiency syndrome (AIDS).Type: GrantFiled: July 14, 1993Date of Patent: July 16, 1996Assignee: Merrell Pharmaceuticals Inc.Inventors: Brigitte Lesur, Jean-Bernard Ducep, Charles Danzin
-
Patent number: 5534551Abstract: A compressed tablet comprising aminoguanidine or a pharmaceutically acceptable salt thereof and a suitably compatible binder prepared by spray drying techniques from an aminoguanidine solution, and methods of making same.Type: GrantFiled: December 22, 1994Date of Patent: July 9, 1996Assignee: Hoechst Marion Roussel, Inc.Inventors: Phillip E. Page, Jonathan Berman, Janet M. Pence, Sharon K. Minish
-
Patent number: 5523442Abstract: Fluorinated silylated aromatic compounds, their intermediates, methods of use in treating diseases associated with deficiencies of cholinergic transmission in the central nervous system and methods for their preparation are disclosed.Type: GrantFiled: July 18, 1995Date of Patent: June 4, 1996Assignee: Merrell Pharmaceuticals Inc.Inventors: Jean-Noel Collard, Jean-Marie Hornsperger
-
Patent number: 5512698Abstract: This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.Type: GrantFiled: April 11, 1995Date of Patent: April 30, 1996Assignee: Merrell Pharmaceuticals Inc.Inventor: Patrick Casara
-
Patent number: 5510373Abstract: This invention relates to certain hydroxy derivatives of 3,4-dihydro-2,5,7,8-tetraalkyl-2H-1-benzopyran-2-carboxylic acids and the lactones thereof, to the processes and intermediates useful for their preparation and to their use as free radical scavengers useful in the treatment of tissue damage implicated with free oxygen radicals.Type: GrantFiled: October 5, 1994Date of Patent: April 23, 1996Assignee: Merrell Pharmaceuticals Inc.Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
-
Patent number: 5508280Abstract: This invention relates to novel derivatives of 5H-dibenzo (a,d)cycloheptenes, to the processes for their preparation, to their muscarinic receptor antagonist properties and to their end-use application for treating Parkinson's Disease, tardive dyskinesia, and motion sickness.Type: GrantFiled: January 30, 1995Date of Patent: April 16, 1996Assignee: Merrell Pharmaceuticals, Inc.Inventors: Marcel Hibert, Luc Van Hijfte, Mary Richards, Paul Moser
-
Patent number: 5508287Abstract: This invention relates to 5-chloro-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acid-octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester (I), a novel 5-HT.sub.3 -receptor antagonist, its method of preparation, and to its end-use application in the treatment or radio- and chemo-therapeutically-induced nausea and vomiting, in the treatment or pain associated with migraine, in the treatment of cognitive disorders, in treating hallucinatory endogenous psychoses or the type manifested in patients suffering from schizophrenia and mania, for irritable bowel syndrome, and to combat drug abuse.Type: GrantFiled: August 16, 1994Date of Patent: April 16, 1996Assignee: Merrell Pharmaceuticals Inc.Inventor: Maurice W. Gittos
-
Patent number: 5504078Abstract: This invention relates to novel polyglycosidyl derivatives of 1-deoxy-nojirimycin, to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes.Type: GrantFiled: December 7, 1992Date of Patent: April 2, 1996Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Jean-Bernard Ducep, Charles Danzin
-
Patent number: 5484810Abstract: This invention relates to alkylated sulfonium alkylene derivatives of certain 2H-1-benzopyrans, to the intermediates and processes useful for their preparation, to their free-radical scavenger and cardioprotective properties and to their end-use application as therapeutic agents.Type: GrantFiled: February 28, 1995Date of Patent: January 16, 1996Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
-
Patent number: 5473099Abstract: This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.Type: GrantFiled: April 11, 1995Date of Patent: December 5, 1995Assignee: Merrell Dow Pharmaceuticals Inc.Inventor: Patrick Casara
-
Patent number: 5440065Abstract: This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.Type: GrantFiled: July 22, 1994Date of Patent: August 8, 1995Assignee: Merrell Dow Pharmaceuticals Inc.Inventor: Patrick Casara
-
Patent number: 5380936Abstract: This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.Type: GrantFiled: January 19, 1994Date of Patent: January 10, 1995Assignee: Merrell Dow Pharmaceuticals Inc.Inventor: Patrick Casara
-
Patent number: 5371093Abstract: Piperidinyl thiacyclic derivatives ##STR1## wherein X, Y, R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are defined in the specification. useful in the treatment of allergic diseases and diseases responding to antagonism of 5HT.sub.2 receptors, pharmaceutical compositions and a methods of treatment using these compounds.Type: GrantFiled: February 24, 1994Date of Patent: December 6, 1994Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Albert A. Carr, George D. Maynard, John M. Kane, Hsien C. Cheng, Mark W. Dudley
-
Patent number: 5270336Abstract: Derivatives of 3,4-dihydroxy-2,5-dihydrofuran-5-ones, intermediates and processes useful for their preparation are disclosed. These compounds are useful as free-radical scavengers and exhibit cellular protective properties.Type: GrantFiled: August 26, 1992Date of Patent: December 14, 1993Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Gilbert Marciniak, J. Martin Grisar
-
Patent number: 5252587Abstract: This invention relates to novel N-derivatives of 1-deoxy nojirimycin, to the method for their preparation and to their use in the treatment of diabetes and the use against retro-viruses, particularly in the treatment of acquired immuno-deficiency syndrome (AIDS).Type: GrantFiled: June 15, 1992Date of Patent: October 12, 1993Assignee: Merrell Dow Pharmaceuticals, Inc.Inventors: Brigitte Lesur, Jean-Bernard Ducep, Charles Danzin
-
Patent number: 5182387Abstract: Novel bis-dibenzoazepine compounds useful in the treatment of malaria and drug-resistant malaria.Type: GrantFiled: October 30, 1991Date of Patent: January 26, 1993Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Jules Freedman, Alan J. Bitonti
-
Patent number: 5175188Abstract: Derivatives of 3,4-dihydroxy-2,5-dihydrofuran-5-ones, intermediates and processes useful for their preparation are disclosed. These compounds are useful as free-radical scavengers and exhibit cellular protective properties.Type: GrantFiled: January 10, 1992Date of Patent: December 29, 1992Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Gilbert Marciniak, J. Martin Grisar
-
Patent number: 5109006Abstract: This invention relates to novel derivatives of 1,7'-[imidazo-[1,2-a]pyridine]5'-(6'H)ones, to the method for their preparation and to their use as anti-hypertensive, anxiety, anti-depressant and anti-migraine agents, and to their use as appetite regulators useful for the treatment of anorexia and obesity.Type: GrantFiled: August 22, 1991Date of Patent: April 28, 1992Assignee: Merrell Dow Pharmaceuticals Inc.Inventor: Marcel Hibert
-
Patent number: 5097023Abstract: This invention relates to novel N-glycosyl derivatives of 1,4-dideoxy-1,4-imino-D-arabinitol, to the chemical processes for their preparation, to their .alpha.-glucosidase inhibiting properties, and to their end-use application in the treatment of diabetes, obesity and those diseases associated with retroviruses, particularly the HIV virus reported to be the causative of the acquired immune deficiency syndrome (AIDS).Type: GrantFiled: September 17, 1990Date of Patent: March 17, 1992Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Jean-Bernard Ducep, Charles Danzin